| Expedient access to 2, 3-dihydropyridines from unsaturated oximes by Rh (III)-catalyzed C–H activation F Romanov-Michailidis, KF Sedillo, JM Neely, T Rovis Journal of the American Chemical Society 137 (28), 8892-8895, 2015 | 116 | 2015 |
| Phosphine/photoredox catalyzed anti-Markovnikov hydroamination of olefins with primary sulfonamides via α-scission from phosphoranyl radicals AJ Chinn, K Sedillo, AG Doyle Journal of the American Chemical Society 143 (43), 18331-18338, 2021 | 54 | 2021 |
| Atropisomerism by design: discovery of a selective and stable phosphoinositide 3-kinase (PI3K) β inhibitor J Chandrasekhar, R Dick, J Van Veldhuizen, D Koditek, EI Lepist, ... Journal of Medicinal Chemistry 61 (15), 6858-6868, 2018 | 48 | 2018 |
| Bioinspired Supercharging of Photoredox Catalysis for Applications in Energy and Chemical Manufacturing A Millet, PT Cesana, K Sedillo, MJ Bird, GS Schlau-Cohen, AG Doyle, ... Accounts of chemical research 55 (10), 1423-1434, 2022 | 23 | 2022 |
| Discovery of an atropisomeric PI3Kβ selective inhibitor through optimization of the hinge binding motif S Perreault, F Arjmand, J Chandrasekhar, J Hao, KS Keegan, D Koditek, ... ACS Medicinal Chemistry Letters 11 (6), 1236-1243, 2020 | 12 | 2020 |
| Small-molecule agents for the treatment of inflammatory bowel disease KS Currie, L Patel, KF Sedillo Bioorganic & Medicinal Chemistry Letters 29 (16), 2034-2041, 2019 | 12 | 2019 |
| Phosphatidylinositol 3-kinase inhibitors J Chandrasekhar, D Naduthambi, L Patel, S Perreault, G Phillips, ... US Patent 10,479,770, 2019 | 11 | 2019 |
| Imidazopyridine derivatives PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent 11,174,256, 2021 | 6 | 2021 |
| Compounds for inhibition of alpha 4 beta 7 integrin PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent 11,224,600, 2022 | 5 | 2022 |
| Compounds for inhibition of α4β7 integrin PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent 11,179,383, 2021 | 5 | 2021 |
| Quinoline derivatives PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent 11,116,760, 2021 | 4 | 2021 |
| Phosphatidylinositol 3-kinase inhibitors J Chandrasekhar, JA Codelli, D Naduthambi, L Patel, S Perreault, ... US Patent 10,214,519, 2019 | 2 | 2019 |
| Compounds for inhibition of alpha 4 beta 7 integrin PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent App. 17/550,591, 2022 | 1 | 2022 |
| Compounds for inhibition of alpha 4 beta 7 integrin PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent App. 17/508,267, 2022 | 1 | 2022 |
| Imidazopyridine derivatives PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent App. 17/500,380, 2022 | 1 | 2022 |
| Quinoline derivatives as alpha4beta7 integrin inhibitors PA Blomgren, TL Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent App. 17/289,614, 2022 | 1 | 2022 |
| Cooperative Phosphine-Photoredox Catalysis Enables N–H Activa-tion of Azoles for Intermolecular Olefin Hydroamination K Sedillo, F Fan, R Knowles, A Doyle | | 2024 |
| Quinoline derivatives PA Blomgren, T Campbell, J Chandrasekhar, CT Clark, JA Codelli, ... US Patent App. 17/379,175, 2023 | | 2023 |
| Phosphine/Photoredox Catalyzed anti-Markovnikov Hydroamination of Olefins with Primary Sulfonamides via a-Scission from Phosphoranyl Radicals A Chinn, K Sedillo, A Doyle | | 2021 |
